title: Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.
abstract: Several studies demonstrated that oxidative damage is a characteristic feature of many neurodegenerative diseases. The accumulation of oxidatively modified proteins may disrupt cellular functions by affecting protein expression, protein turnover, cell signaling, and induction of apoptosis and necrosis, suggesting that protein oxidation could have both physiological and pathological significance. For nearly two decades, our laboratory focused particular attention on studying oxidative damage of proteins and how their chemical modifications induced by reactive oxygen species/reactive nitrogen species correlate with pathology, biochemical alterations, and clinical presentations of Alzheimer's disease. This comprehensive article outlines basic knowledge of oxidative modification of proteins and lipids, followed by the principles of redox proteomics analysis, which also involve recent advances of mass spectrometry technology, and its application to selected age-related neurodegenerative diseases. Redox proteomics results obtained in different diseases and animal models thereof may provide new insights into the main mechanisms involved in the pathogenesis and progression of oxidative-stress-related neurodegenerative disorders. Redox proteomics can be considered a multifaceted approach that has the potential to provide insights into the molecular mechanisms of a disease, to find disease markers, as well as to identify potential targets for drug therapy. Considering the importance of a better understanding of the cause/effect of protein dysfunction in the pathogenesis and progression of neurodegenerative disorders, this article provides an overview of the intrinsic power of the redox proteomics approach together with the most significant results obtained by our laboratory and others during almost 10 years of research on neurodegenerative disorders since we initiated the field of redox proteomics.
authors: Department of Chemistry, Center of Membrane Sciences, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA. dabcns@uky.edu
authors: D Allan
authors: DA
authors: Butterfield
authors: Marzia
authors: M
authors: Perluigi
authors: Tanea
authors: T
authors: Reed
authors: Tasneem
authors: T
authors: Muharib
authors: Christopher P
authors: CP
authors: Hughes
authors: Renã A S
authors: RA
authors: Robinson
authors: Rukhsana
authors: R
authors: Sultana
mesh_terms: D000447:Aldehydes / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000378:metabolism*; D015227:Lipid Peroxidation; D050216:Metabolic Detoxication, Phase I; D019636:Neurodegenerative Diseases / Q000145:classification / Q000378:metabolism / Q000473:pathology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D050050:Protein Carbonylation; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000032:analysis / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D026361:Reactive Nitrogen Species / Q000378:metabolism
chemical_list: D000447:Aldehydes; D011506:Proteins; D026361:Reactive Nitrogen Species; D007501:Iron; C027576:4-hydroxy-2-nonenal